...

Korle Bu Defends Lab Results as Dispute Raises Patient Safety Questions

Korle Bu Teaching Hospital has defended the reliability of its Central Laboratory after a dispute involving doctors and laboratory scientists briefly disrupted outpatient care and prompted a Ministry of Health review.

Follow Nukunya
Get the latest breaking news and updates from Nukunya.
Korle Bu Teaching Hospital says results from its Central Laboratory remain reliable and internationally accredited after doctors raised concerns during a dispute that briefly disrupted outpatient care. The controversy has also exposed a deeper disagreement over laboratory governance and professional responsibilities at Ghana’s leading referral hospital.

ACCRA, Ghana – Korle Bu Teaching Hospital has defended the reliability of tests produced by its Central Laboratory after a professional dispute involving doctors and medical laboratory scientists raised questions about laboratory governance, clinical decision-making and patient safety at Ghana’s largest teaching hospital.

Hospital management said in a formal statement on 7 May that the laboratory’s results remained valid and reliable, rejecting reports that had cast doubt on the quality of its diagnostic services. The statement said the laboratory operates under internationally recognised accreditation and is staffed by qualified professionals. The intervention followed several days of disagreement involving the Korle Bu Doctors Association, KODA, and medical laboratory professionals over access to the Central Laboratory, professional responsibilities, and its management structure.

The dispute briefly affected patients when doctors withdrew outpatient services on 4 May. The action was suspended later that day after hospital management gave assurances addressing some of the doctors’ concerns.

The Ministry of Health subsequently established a Technical Review Committee to examine the laboratory dispute, including questions of professional collaboration, operational coordination and management structures. The controversy therefore extends beyond competing professional interests. Laboratory results influence diagnoses, medication, surgery and other clinical decisions, making confidence in the systems used to produce and interpret those results an important public-health issue.

Korle Bu Teaching Hospital Central Laboratory in Accra, Ghana
Korle Bu Teaching Hospital in Accra has defended the reliability of results from its Central Laboratory following a professional dispute over laboratory operations and governance.

What Korle Bu says about its laboratory

In its 7 May statement, Korle Bu management described reports questioning the quality and reliability of Central Laboratory results as misleading. The hospital said the facility was among the most advanced and well-equipped laboratories in Ghana and the West African sub-region and served as a training centre for laboratory scientists from health institutions across the country.

Management also cited the laboratory’s accreditation under ISO 15189:2022, the international standard covering quality and competence requirements for medical laboratories.

“Management assures all and sundry that the results generated by the laboratory are valid and reliable,” the hospital said in its statement.

The hospital said it remained committed to strengthening the laboratory’s role in clinical care, diagnostics and teaching while investing in its capacity to provide accurate and timely services.

The accreditation is relevant evidence about the laboratory’s quality-management framework. It should not, however, be interpreted as proof that an individual laboratory result can never be questioned or require clinical review. That distinction matters because medical testing involves processes ranging from sample collection and handling to analysis, interpretation and communication of results.

Korle Bu Defends Lab Results as Dispute Raises Patient Safety Questions Nukunya

What doctors had raised concerns about

The Korle Bu Doctors Association announced the withdrawal of outpatient services from 4 May amid what it described as concerns over patient safety and clinical decision-making.

The association linked its action to a prolonged disagreement at the Central Laboratory, including access for laboratory physicians and the validation of specialised laboratory results. Doctors called for specialised results to be reviewed and validated by appropriately qualified laboratory physicians before release and sought unrestricted access to laboratory systems and equipment for clinical and academic work.

The industrial action had immediate consequences.

Some patients arriving for specialist consultations were unable to access routine outpatient services, while emergency and critical cases continued to receive care. Reports from the hospital described patients being turned away or redirected while the dispute continued.

The action was short-lived.

KODA suspended it after an emergency meeting with management on 4 May. The association said it had received assurances that laboratory physicians would be able to return to their designated workplaces. Normal outpatient services were expected to resume the following day.

Laboratory scientists rejected the claims.

Medical laboratory scientists strongly challenged allegations questioning the Central Laboratory’s results. The Korle Bu chapter of the Ghana Association of Medical Laboratory Scientists rejected claims attributed to KODA about the reliability of laboratory results and demanded a retraction and apology.

The scientists also opposed attempts to place laboratory services under professional leadership arrangements they considered inconsistent with their responsibilities. Their position was supported by the laboratory’s accreditation, which they cited as evidence that its systems were subject to external quality and competence requirements.

The dispute therefore developed along two related but distinct tracks.

One concerned the reliability and clinical oversight of laboratory testing.

The other concerned should exercise professional and administrative authority over laboratory services. Conflating those questions risks presenting what is partly a governance dispute as evidence that the laboratory itself is unsafe.

A deeper dispute over who manages the laboratory

The leadership question became increasingly prominent as the disagreement developed.

The Ghana Federation of Allied Health Professions at Korle Bu objected to management’s decision to withdraw the appointment of the Head of Laboratory Services and change oversight arrangements for the Central Laboratory.

The Medical Laboratory Professional Workers’ Union, MELPWU, also challenged the decision and initially announced nationwide industrial action over the matter.

The union said earlier agreements reached during a Ministry of Health stakeholder meeting on 3 February had not been respected.

The dispute was therefore no longer confined to Korle Bu.

A disagreement at one laboratory had developed into a broader argument over professional boundaries and the governance of laboratory medicine within Ghana’s health system.

The Ministry of Health intervenes.

The Ministry of Health stepped in following discussions involving Korle Bu management, KODA and laboratory professionals. A Technical Review Committee was established to conduct what the ministry described as an objective review of the issues affecting laboratory services.

Its remit included professional collaboration, operational coordination and management structures within Korle Bu’s laboratory system.

That intervention is significant.

A sustainable resolution requires more than restoring access to a laboratory or deciding who occupies a particular management position. It also requires clearly defined professional responsibilities and systems capable of maintaining clinical confidence when disagreements arise. The controversy continued after the immediate OPD disruption ended. By 15 May, laboratory professional workers were still pressing for changes to the management arrangements while the ministry’s review process continued.

CASE TIMELINE

Timeline: How the Korle Bu laboratory dispute developed

03 May

Doctors signal withdrawal of services

KODA announces plans to withdraw outpatient services, citing concerns involving laboratory operations and patient safety.

04 May

OPD services withdrawn

Doctors withdraw outpatient services at Korle Bu, affecting patients seeking routine consultations.

04 May

Laboratory scientists reject reliability claims

Medical laboratory scientists publicly reject allegations questioning the reliability of laboratory results.

04 May

Industrial action suspended

Following an emergency meeting with management, KODA suspends its industrial action.

05 May

Allied health professionals object

Allied health professionals object to changes involving leadership of laboratory services.

07 May

Korle Bu defends Central Laboratory

Hospital management issues a formal statement defending the Central Laboratory and its results, citing ISO 15189:2022 accreditation.

07 May

Ministry of Health steps in

The Ministry of Health establishes a Technical Review Committee to examine the underlying operational and governance issues.

15 May

Governance dispute continues

Laboratory professionals continue pressing their governance demands while the review process remains under way.

EXPLAINER

What does ISO 15189 accreditation mean?

ISO 15189 is an international standard specifically developed for medical laboratories.

01

Competence

Accreditation provides evidence that a laboratory has been assessed against requirements covering professional competence and testing processes.

02

Quality systems

It also covers quality-management systems designed to support consistent and reliable laboratory practice.

03

Patient safeguard

For patients, independent accreditation provides an important institutional safeguard.

Important distinction

Accreditation should not be presented as a guarantee that every individual result produced by an accredited laboratory is automatically beyond question.

Clinical medicine depends on several layers of quality control. Doctors may sometimes request repeat testing, additional investigations or clinical interpretation where a result appears inconsistent with a patient’s symptoms or other evidence.

That is why the central public-interest question raised by the Korle Bu dispute is not simply which professional group should control the laboratory.

It is whether Ghana’s health institutions have sufficiently clear governance arrangements to ensure that disagreements between professional groups do not interrupt patient care or undermine public confidence in diagnostic services.

NUKUNYA CONTEXT

Why this story matters

Korle Bu is not an ordinary health facility.

As Ghana’s leading tertiary referral and teaching hospital, it treats complex cases referred from across the country and plays an important role in training doctors and other healthcare professionals.

National significance Its Central Laboratory is therefore part of critical national health infrastructure.

Laboratory medicine often operates outside public view, but its results influence decisions across virtually every major area of clinical care.

When professionals responsible for different parts of that system disagree over authority, access or validation procedures, the consequences can extend beyond an internal employment dispute.

The temporary withdrawal of outpatient services demonstrated that risk.

For patients

The immediate reassurance is that Korle Bu management has publicly defended the laboratory’s standards and reliability and cited international accreditation in support of that position.

For policymakers

The longer-term issue is whether the Ministry of Health’s review can establish a durable governance framework that commands confidence across the professions involved.

Until that process is resolved, claims about the laboratory’s reliability and claims about professional responsibilities should remain clearly distinguished.

That distinction protects patients from unnecessary alarm while ensuring legitimate questions about governance and clinical accountability are not dismissed.

PATIENT GUIDANCE

What patients should know

Korle Bu has not announced that its Central Laboratory results are generally unreliable.

The hospital has stated the opposite and says its laboratory remains internationally accredited and professionally operated.

1

Do not assume your result is wrong

The institutional dispute does not, by itself, establish that an individual patient’s laboratory result is incorrect.

2

Speak to your treating clinician

Patients concerned about a particular laboratory result should discuss it with the doctor responsible for their care.

3

Understand what the review concerns

The Ministry of Health’s intervention concerns the wider governance and operational dispute surrounding laboratory services.

This explainer provides general information and should not replace individual clinical advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.